The Long-Term Effects of AI Deployment

  |   By  |  0 Comentarios

Photo courtesyDrew T. Matus, Chief Market Strategist at MetLife Investment Management.

The second edition of the Funds Society Leaders Summit, held in collaboration with CFA Society Spain, featured an analysis by MetLife Investment Management, in which Drew T. Matus, Chief Market Strategist at the firm, focused on how he views the world right now and how he believes it will evolve; its risks and, above all, the impact of artificial intelligence.

Matus stated that growth is being driven primarily by AI: the United States and Korea are experiencing accelerated growth, but the rest of the world is facing some difficulties in recovering from last year’s weakness. All of this occurs within a context of inflation and high yields, “which is not necessarily a bad thing.”

The expert observes that, despite geopolitical volatility and inflation, recession expectations in any of these regions remain quite low. “People feel very comfortable that the status quo will hold indefinitely, which is somewhat strange given that yields are normalizing and there is significant geopolitical risk,” he comments, pointing out that the only country behaving remotely abnormally compared to the recent period is Japan.

Matus explains that artificial intelligence, as it spreads across the globe and is used more frequently in different regions, “could narrow the gap between the United States and the rest of the world in terms of productivity growth, which would imply reducing the differential in potential GDP growth.” This circumstance could provide a solution to issues such as government deficits, because according to the expert, “if you manage to grow out of the deficit, you will be in a fairly favorable position.”

However, according to Matus, the future could bring either a narrowing or a widening of this gap. Ultimately, “it will depend on policymakers, in this case in Europe, although the same applies to parts of Asia,” meaning “it is up to policymakers to determine whether they want to close this gap or not, and how to regulate the emerging technologies that could enable it.”

Risks

One of the main risks Matus sees regarding AI does not lie in the promise of the technology itself. CEOs believe it is enough to simply implement this technology in their companies and that giving everyone access to the tool will solve everything on its own. “But the reality is that you need a company designed to use the new technology,” he notes. From an operational standpoint, leveraging it is far more difficult than at any previous time, and now “CEOs have begun to realize that they have made many promises they cannot keep.”

Matus highlights the lack of evidence suggesting that AI is leaving young people out of work. In fact, in the United States, hiring is happening, but for experienced workers, “which is precisely the opposite of what is intended with AI, because experienced workers are the ones who can be replaced and are usually more expensive.” Ultimately, he observes neither an increase in unemployment or underemployment, nor high productivity levels in the United States. Specifically, the latest quarterly figures align with the average of the last 10 years, and even the last 50 years. “If we look for AI in the data, we haven’t found it yet,” he states. Therefore, he sees an opportunity for the markets, “as we have not yet seen the positive impact of AI on the broader economy, neither in the United States nor, frankly, anywhere else.”

Another aspect Matus finds concerning is that a sector that should benefit from artificial intelligence and all the productivity gains it brings—the financial sector—is not experiencing a strong market run on par with the tech sector or the broader market. “The market has bought into the idea that AI will be a revolutionary technology, but conclusive proof is still lacking,” Matus notes.

Ultimately, the expert concludes that the market is betting on short-term optimism around AI. But the reality is that AI will take time to integrate into the economy. For this reason, he anticipates that as AI spreads throughout the economy, “it will have all the effects that are promised in the short term, but we won’t see them anytime soon.”

The Long Term

How do we expect this to play out in the long term? To understand productivity gains in the United States, Matus points to technology and its optimal utilization. The methodology the country used to achieve this—through employee training—was “the right one, whether due to lower regulation or any other reason.”

Matus puts figures on potential U.S. growth through the application of AI: between 4% and 4.5% over the next 10 years, “something we have never seen before in a developed market economy.” It would only be comparable to what was seen following China’s entry into the WTO. Matus highlights at this point that this is one of the reasons why, when analyzing the U.S. deficit or perceiving that Americans do not care about it, “it is because we really don’t care; we believe we can outgrow it.”

There will also be shifts in the economy, as has happened in other technological revolutions. In fact, Matus does not rule out that some of the largest companies in 2025 will no longer hold those positions in the future, just as occurred with the giants of the 1990s. What became clear then—and what Matus considers a risk when weighing artificial intelligence and all the changes occurring in the global economy—is that the companies that figured out how to use the new technology are precisely the ones that made it into that group.

“One or two of them are directly related to technology, but in general, they simply take a different approach to new technologies. So, when reflecting on what the world will look like in 2035, 2040, and 2050, the winners and losers will not necessarily be the names appearing today on the front pages of the Financial Times and The Wall Street Journal. It is really about companies that are figuring out how to use the technology being offered to them,” he concludes.

State Street Names Mostapha Tahiri President of Its Alpha Platform and Ann Fogarty Chief Operating Officer

  |   By  |  0 Comentarios

Canva

State Street Corporation has announced the appointment of new executives to support the next phase of the firm’s growth strategy and its continued focus on driving innovation and transformation to help clients achieve better outcomes in increasingly complex global markets. Specifically, Mostapha Tahiri, previously Chief Operating Officer, will become President of State Street Alpha, assuming responsibility for Alpha, Charles River Development (CRD), and a suite of innovative platform solutions; and Ann Fogarty, previously Chief Operating Officer of Investment Services, has been named Enterprise Chief Operating Officer.

Regarding Tahiri’s appointment, the firm clarifies that Alpha is State Street’s leading end-to-end (front-to-back) integrated platform, combining CRD’s front-office technology with the firm’s servicing, markets, and data capabilities to offer investors a single platform experience across the entire investment lifecycle. Drawing on his deep commercial, client, technological, AI, and operational experience, Tahiri will assume end-to-end responsibility for commercial strategy, product strategy, technology, and client delivery for Alpha and CRD. Leveraging the strength of this platform, Tahiri will focus on accelerating growth, strengthening execution, transforming the operating model, and maximizing the full potential of innovation across the business.

Tahiri will also serve as Chair for Asia-Pacific (APAC). Having spent much of his career serving clients in APAC and following his recent return to Singapore, Tahiri is ideally positioned to oversee State Street’s business relationships in the region with key clients, regulatory bodies, and strategic partners. He will continue to serve on State Street’s Executive Committee. This executive has nearly 30 years of international experience in the asset management, asset servicing, investment platforms, and financial technology sectors. His track record includes leading and transforming complex global businesses and driving initiatives where clients, technology, and operations intersect.

Another announced change affects Ann Fogarty, previously Chief Operating Officer of Investment Services, who has been named Enterprise Chief Operating Officer, succeeding Tahiri. In her new role, she will also report to O’Hanley. As Enterprise Chief Operating Officer, she will lead the firm’s global technology and operations areas and drive State Street’s technological modernization and AI agenda, reflecting the growing convergence of technology, operations, data, resilience, and client service across the industry. She will continue to co-lead the firm’s global transformation program alongside John Woods, Chief Financial Officer (CFO), helping accelerate innovation, build greater scale and efficiency, reduce cycle times, and further strengthen the quality of client outcomes across State Street’s businesses. Fogarty will continue to serve on the firm’s Executive Committee. Fogarty brings nearly four decades of industry experience. She has led key client operations for Investment Services, where she drove operational simplification, resilience, and enterprise-wide global transformation initiatives. Fogarty also chairs the Supervisory Board of State Street Bank International GmbH (SSBI), our principal European bank.

Following these changes, Ron O’Hanley, Chairman and Chief Executive Officer (CEO) of State Street, highlighted: “Our clients face increasingly complex markets and operating environments, and are demanding with increasing frequency that technology and operations function seamlessly together. Mostapha’s focus on Alpha—one of State Street’s most differentiating businesses and a core strategic priority for the firm—and Ann’s leadership in global operations and technology provide dedicated direction in areas that drive how we create value for clients. These appointments reinforce the strength of our leadership team and position us to continue executing for clients while investing in the future of our business.”

Together, these appointments establish dedicated leadership in two key areas critical to client needs and the firm’s long-term strategy. They also reflect State Street’s commitment to leading alongside its clients as technology, AI, data, and operations shape the future of investment and investment infrastructure. Both appointments are effective as of 09/14/2026.

Allianz Global Investors and BTG Pactual Seal a Distribution Agreement for US Offshore and Latin America

  |   By  |  0 Comentarios

Photo courtesyAlexandra Auer, Head of Distribution for EMEA at Allianz Global Investors

Allianz Global Investors (AllianzGI) and BTG Pactual have announced a strategic distribution alliance for the US Offshore market and several Latin American countries, including Brazil, Argentina, and Uruguay. Under the agreement, BTG Pactual will distribute AllianzGI’s active investment strategies in public and private markets.

As highlighted in a press release, the alliance combines AllianzGI’s global expertise in investment and active management with BTG Pactual’s consolidated regional distribution network, its local market knowledge, and its strong client relationships. The collaboration will expand investors’ access to international strategies, backed by customer service with a local focus.

The agreement, they stressed, reinforces AllianzGI’s commitment to the US Offshore market, a strategic priority for the firm, and reflects its goal to continue expanding its presence in Brazil, Argentina, and Uruguay.

“Latin America is a strategic market for Allianz Global Investors, and this alliance with BTG Pactual represents an important step toward continuing to drive and strengthen our presence in the region. BTG Pactual’s local expertise, strong client relationships, and consolidated distribution network make it a key partner for AllianzGI. Together, we will be able to better respond to the needs of US Offshore investors and expand access to our active investment strategies in Brazil, Argentina, Uruguay, and other markets across the region,” said Alexandra Auer, Head of Distribution for EMEA at Allianz Global Investors.

“We are pleased to deepen our relationship with Allianz Global Investors through this strategic alliance, which is fully aligned with our goal of collaborating with leading international asset managers to offer our clients access to top-tier investment solutions. This collaboration will allow us to expand access to AllianzGI’s investment capabilities for clients in the US offshore and Latin American markets. Our distribution activities will be driven by a dedicated team of more than 30 professionals, who will work closely with AllianzGI to foster the long-term development of this business. We are confident in building a strong, successful, and lasting partnership,” stated Rubens Henriques, Managing Partner and CEO of BTG Pactual Asset Management.

Mexico Investment Week: How to Attract More Capital?

  |   By  |  0 Comentarios

Photo courtesy

Mexico arrived in New York with a paradox on the table: the country is experiencing a record moment in foreign direct investment (FDI), but most of these resources do not represent new capital entering the country.

During the first half of 2026, Mexico captured $34.968 billion in FDI, the highest amount recorded for a comparable period. However, 88.5% corresponded to reinvestment of earnings, shifting the challenge from retaining capital already in the country to persuading new investors to allocate resources to companies, infrastructure, and productive projects.

Against this backdrop, the Institutional Stock Exchange (BIVA) held the seventh edition of Mexico Investment Week in New York, bringing together Mexican authorities, business leaders, financial institutions, multilateral organizations, and investors to discuss the necessary conditions for turning international interest in Mexico into new capital flows.

The agenda highlighted several key issues that will shape the next stage of the U.S.-Mexico economic relationship: the future of the USMCA, North American productive integration, the development of capital, fixed income, and credit markets, as well as investment opportunities in energy, water, and infrastructure.

The effort is highly relevant to the Mexican financial market because the challenge of attracting additional investment goes beyond traditional foreign direct investment. It also involves the country’s capacity to channel institutional and private capital toward long-term projects and leverage the stock market as an additional financing source.

From Interest to New Capital Flows

Concrete signals of market appetite for Mexico emerged during the event. René Saúl, CEO and co-founder of Kapital Bank, announced a $125 million funding round in equity and debt, raising the company’s valuation to $2 billion and establishing it, according to information shared at the event, as Latin America’s first artificial intelligence unicorn.

The announcement served as evidence that international interest in Mexico can materialize in technology and financial services companies capable of attracting global capital.

Another discussion framed the potential scale of private equity investment in Mexico. It was estimated that firms such as Apollo Global Management could deploy up to $20 billion in domestic projects over the coming years, primarily in infrastructure, energy, and corporate credit.

This figure highlights one of the key areas where Mexico aims to broaden its appeal: private markets, where large international investors can participate in projects requiring extended investment horizons and capital commitments larger than those traditionally handled by public stock markets.

For BIVA, the primary objective is to bridge this capital with domestic opportunities. María Ariza, CEO of BIVA, stated that Mexico Investment Week aims to serve as a bridge between both markets and build the framework to convert investor interest into long-term relationships and investment opportunities.

“Mexico Investment Week today represents much more than a meeting; it is a bridge connecting two nations, two markets, and two cultures that share a common vision: driving economic growth, innovation, and investment,” she stated.

Mexico and the U.S.: A Relationship That Can Outweigh Tariffs

Trade relations with the United States dominated much of the dialogue, particularly amid uncertainty regarding the USMCA’s future and commercial policies coming out of Washington.

Kate Kalutkiewicz, Senior Managing Director at McLarty Associates, noted during the event that 89% of Mexican exports enter the United States duty-free—a status that, in her view, preserves Mexico’s competitiveness as an investment hub.

The executive also emphasized that no other country possesses comparable access to the U.S. market and minimized expectations of a U.S. withdrawal from the USMCA. The discussion carries added weight as global corporations redefine supply chains to mitigate geopolitical and logistical risks.

For Mexico, the opportunity lies in converting its trade integration with the United States into an advantage for attracting new manufacturing plants, infrastructure, suppliers, logistics hubs, and supply chain services. However, geographic proximity alone is insufficient.

Investors also demand legal certainty, predictable tax rules, adequate infrastructure, and physical conditions suitable for developing long-term projects. Finding the right balance among these factors remains central to competing for global capital.

Mexico’s Geopolitical Thesis

Roberto Lazzeri, Mexico’s Ambassador to the United States, shifted the discussion toward a broader domain: the evolving geopolitical landscape. The diplomat pointed out that the U.S. government is sharpening its focus on the Western Hemisphere, positioning Mexico at the center of this new dynamic.

“There is a shift in the U.S. government’s focus toward the Western Hemisphere, and the gateway to that hemisphere is Mexico; it is the strongest investment thesis you can find,” he declared.

This thesis relies on an underlying economic reality: Mexico is the main trading partner of the United States and is deeply integrated into the North American productive network. This integration makes the country a prime beneficiary of supply chain realignments, while simultaneously raising demands for infrastructure, energy, water, logistics, and financing.

The primary task is ensuring this geopolitical advantage moves beyond a promotional narrative and yields tangible, realized projects.

Capital Markets Seek a Larger Role

In this environment, BIVA’s participation carries implications that extend beyond international promotion; public capital markets can serve as a primary mechanism for transforming investor interest into long-term funding for corporations and infrastructure. Achieving this, however, will require expanding Mexico’s issuer base, boosting investor participation, and deepening market liquidity.

The Mexico Investment Week agenda specifically covered discussions on fixed income, credit, and capital markets, Alongside sector-specific opportunities in energy, water, and infrastructure.

The core logic remains clear: if Mexico aims to capitalize on the next cycle of North American integration, it will require substantial capital volumes.

A portion will come from FDI; another share from commercial banks and private markets; and additional funds from institutional investors and public capital markets.

The scale of the challenge is reflected in the composition of recent FDI flows. The nearly $35 billion captured in the first half shows that Mexico retains strong fundamentals for attracting foreign capital. However, with nearly nine out of every ten dollars coming from reinvested earnings, significant room remains for drawing brand-new projects and greenfield investments.

Consequently, BIVA’s objective in New York extended beyond presenting Mexico as an attractive destination, focusing instead on addressing a more complex core question: how to convert the nation’s trade and geopolitical advantages into new, committed investment decisions.

Mexico Investment Week will continue with activities including a market bell ceremony at Nasdaq, alongside sessions covering economic outlooks, state-level investment opportunities, and fintech ecosystem developments.

Ultimately, the goal is to establish financial channels capable of routing international interest, North American integration, and global supply chain realignments directly toward companies and projects seeking expansion capital.

Record FDI figures confirm that Mexico remains an attractive market; the immediate test is converting that attraction into new money, productive investment, and long-term capital deployment.

The US Sets the Pace While Emerging Markets Accelerate the Global “Ultra-Rich” Factory

  |   By  |  0 Comentarios

Photo courtesyThe Wealth Report 2026 (Knight Frank)

Global wealth creation has surged at an extraordinary pace over the last five years. According to the new Wealth Sizing Model included in The Wealth Report 2026 by Knight Frank, the global population of Ultra-High-Net-Worth Individuals (UHNWIs)—defined as those with net assets exceeding $30 million—has expanded from 551,435 in 2021 to reach 713,626 worldwide.

As detailed in the document, this rapid expansion has been decisively dominated by the United States, which generated 41% of new ultra-high-net-worth individuals thanks to the depth and liquidity of its capital markets, as well as the powerful multiplier effect of the technology sector and artificial intelligence (AI). Meanwhile, Asia-Pacific and India are consolidating their positions as secondary drivers of structural growth.

Figures from the report reveal that, over the past five years, 89 people around the world crossed the $30 million threshold every single day. The strength of U.S. financial infrastructure will drive the country from concentrating 35% of global UHNWIs in 2026 to a projected 41% by the year 2031, adding more than 136,000 new ultra-high-net-worth individuals. To accommodate this relentless U.S. expansion, nearly every other country—including China, which will drop from its current 17% share to 15%—will see its global market share contract.

However, the report highlights clear geographical dispersion looking ahead, driven by rapidly maturing economies. Indonesia leads percentage growth forecasts, with a projected 82% surge in its UHNWI population by 2031. It is followed closely by Saudi Arabia and Poland (both above 60%), as well as Vietnam (nearly 60%), underscoring the speed at which new wealth hubs are forming, particularly in Southeast Asia and the Middle East.

Global UHNWI and Billionaire Charts. Source: Knight Frank, The Wealth Report 2026

The billionaire segment confirms this shift toward global diversification. Although Asia-Pacific holds the highest total count (1,116 compared to North America’s 965), the fastest growth rates over the next five years will be registered in Saudi Arabia (+183%), Poland (+123%), Sweden (+81%), and Australia (+77%).

The Australian case stands out for its economic resilience and depth: its UHNWI population is projected to grow nearly 60% (reaching 26,095 individuals), supported by an ecosystem combining commodities with an increasingly sophisticated financial services and technology sector.

For its part, India represents a story of large-scale consolidation. After seeing its ultra-wealthy population skyrocket 63% between 2021 and 2026, the country is set to add an additional 27% by 2031, surpassing 25,000 UHNWIs. This progress reflects the transformation of its economy toward a model backed by a deeper equity market, greater private equity penetration, and increasingly established global investment networks.

mRNA Melanoma Vaccine: What the Market Measures and How Health Managers Interpret It

  |   By  |  0 Comentarios

Julia Kung (Groupama AM) a la izquierda, Christian Fay (BNP Paribas AM) en el centro y Sara Torrecilla (Candriam) a la derecha.
Photo courtesy

When Moderna and MSD announced that their personalized mRNA melanoma vaccine had met its primary endpoints in Phase 3, the market did not wait for the fine print. Within hours, both companies added tens of billions of dollars in market capitalization, without a peer-reviewed scientific publication or a complete breakdown of efficacy and safety yet available. Funds Society consulted three fund managers with exposure to the healthcare sector—Candriam, BNP Paribas AM, and Groupama AM—to understand exactly what that price is discounting, and what needs to happen for the bet to hold.

“Investors are assigning value to the possibility that this approach could work across multiple tumor types and treatment settings,” summarizes Sara Torrecilla, Senior Biotech Analyst at Candriam, regarding a stock rally that at its peak added roughly $90 billion in combined market value and settled around $60 billion net. It is, in her words, a warning sign as much as a point of enthusiasm: the peak sales estimates already circulating in the market, in the tens of billions of dollars, “should be viewed as market assumptions, not clinical evidence.”

Groupama AM, manager of the Global Disruption fund, reaches a similar diagnosis from a different angle. “The surge in stock prices for Moderna and Merck reflects a de-risking re-rating of both companies thanks to a historic validation of the mRNA platform, considered ‘first-in-class,'” explains Julia Kung, portfolio manager and international equity and convertible bond analyst at the firm. The market, she adds, “is also betting that this could be expanded beyond melanoma to other tumors, such as non-small cell lung cancer, bladder, kidney, and other cancer types,” even though all that has been published so far is “an interim summary of results across two endpoints” without the complete dataset on risk, statistical confidence, and safety. Stock prices, she reminds, “always look forward,” and reacted this way because this represents the first Phase III success for an individualized neoantigen therapy and for any mRNA-based cancer treatment.

From BNP Paribas AM, Senior Portfolio Manager Christian Fay agrees that the reaction is justified, though he emphasizes the underlying medical need: the interim data showed “statistically significant and clinically meaningful” improvements compared to treatment with Keytruda alone, in a type of melanoma—resected high-risk cutaneous—where unmet medical need remains high. “These results reinforce our conviction that targeted, personalized medicine can be a particularly effective strategy to treat specific types of cancer, such as melanoma,” notes Fay.

Merck, Keytruda, and the Defensive Play

There is a second layer to the story that relates specifically to Merck. Kung, from Groupama, observes that by combining the vaccine with Keytruda, “this collaboration generates a narrative of potential market dominance not only in melanoma, but also across other cancer types where Keytruda is used.” She goes further: “the rally in Merck’s stock price can be interpreted as a successful defensive narrative: that Merck can protect and extend the Keytruda franchise through combination therapies, while also signaling confidence in Merck’s ability to grow beyond Keytruda.” In other words, part of what the market is celebrating is not just the vaccine itself, but the possibility that Merck has found a way to extend the commercial lifespan of its flagship product.

Revolution or Intermediate Step?

It is in the scale of the promise where perspectives begin to diverge. Kung admits that, over the long term, this “could prove to be ‘revolutionary’ and, so to speak, mark the true beginning of the ‘cancer vaccine’ market.” But she qualifies: “at present, it is better characterized as a platform-level inflection point, analogous to the first kinase inhibitor that validated targeted therapy, rather than an immediate restructuring of pharmaceutical leadership.” The reason is two-fold: adjuvant melanoma is “a relatively narrow indication,” and large-scale personalized manufacturing—producing a distinct treatment for every single patient—”remains operationally complex and expensive.”

Candriam frames the same caution within its specific oncology mandate: personalized mRNA vaccines must be “evaluated with the same discipline as other treatment modalities,” in an increasingly multimodal therapeutic landscape where other innovations—such as antibody-drug conjugates and targeted therapies—have already found their place depending on the tumor type. Torrecilla expands the radar beyond pharmaceutical companies: the life sciences supply chain—tumor sequencing, mRNA manufacturing, lipid nanoparticles—added roughly $50 billion in market value on the day of the announcement, according to Jefferies estimates. But she clarifies the limits of that thesis: “no third-party vendor has been publicly confirmed as a direct manufacturing or sequencing partner,” so it is best not to get ahead of assigning that value to specific companies just yet.

BNP Paribas, without a dedicated thematic healthcare fund, resolves the dilemma differently: capturing the thesis through diversified portfolios that collectively exceed $5 billion, with exposure to healthcare and biotech companies that, according to Fay, act as “engines of innovation” for big pharma. The backdrop, he explains, is structural: nearly $200 billion in big pharma sales will be exposed to patent expirations in the coming years, which will keep both innovation and M&A activity high, because internal R&D at major companies is insufficient to fill that gap.

The next real test for all of this comes in October, with the European Society for Medical Oncology (ESMO) Congress, taking place from October 23 to 27 in Madrid. It is one of the most influential events on the global oncology calendar, where the full trial dataset will be shared.

According to Kung, “the gap between top-line data and granular details is where short-term valuation risk is concentrated.” Torrecilla speaks in similar terms: “The market will focus on the magnitude of the benefit,” both to confirm the commercial opportunity in melanoma and to build confidence in extending the approach to other tumors.

Meanwhile, each fund manager maintains their own list of catalysts. Groupama monitors the FDA submission and review of the Biologics License Application (BLA) for adjuvant melanoma, results in non-small cell lung cancer—which they view as “the most closely watched expansion opportunity given its significantly larger potential market”—pricing and reimbursement signals—since “custom production for every patient represents a major commercial constraint” and payers “will establish the revenue ceiling”—and BioNTech’s trial in pancreatic cancer with autogene cevumeran, which “will indicate the extent to which the concept can be generalized across different tumor types.” Candriam adds Phase 1 data in pancreatic cancer and expected renal cell carcinoma results by year-end to that list. BNP Paribas, for its part, closely tracks other industry milestones such as the JP Morgan Healthcare Conference, broadening its view to other areas of healthcare innovation where it identifies similar opportunities.

Active ETFs, Increasingly Important in Investor Portfolios

  |   By  |  0 Comentarios

Photo courtesyTom Stephens, Head of ETFs at Schroders.

Active ETFs are leaving behind their status as a niche allocation to become an increasingly relevant element in portfolio construction. The Schroders Global Investor Insights Study 2026 (GIIS) shows that investors are seeking to combine active management with the operational advantages inherent to ETFs, overcoming the perception of these vehicles as a mere lower-cost alternative to mutual funds.

Active ETFs are leaving behind their status as a niche allocation to become an increasingly relevant element in portfolio construction. The Schroders Global Investor Insights Study 2026 (GIIS) shows that investors are seeking to combine active management with the operational advantages inherent to ETFs, overcoming the perception of these vehicles as a mere lower-cost alternative to mutual funds.

Thus, globally, virtually all respondents (98%) recognize that active ETFs have a role to play in portfolios (compared to only 2% who believe otherwise), shifting the debate: it is no longer about whether to use them, but how to get the most out of them.

This shift is especially relevant in the current market environment. In a setting marked by higher volatility and persistent uncertainty, investors need tools that allow them to act quickly, closely monitor their positions, and adjust them with agility, without giving up the added value of active management.

Cost is no longer everything

Regarding the factors investors place the most importance on when evaluating an active ETF, cost is cited without hesitation. Lower costs compared to mutual funds are the main advantage for 70% of respondents. But interest in these products is no longer limited to cheaper access to active management. For more than half of respondents worldwide (51%), intraday liquidity and the ability to trade at market prices, along with higher liquidity in the secondary market (55%) compared to equivalent mutual funds, are other major arguments in favor of this investment vehicle. This is because active ETFs can be bought and sold continuously, often supported by market makers. In contrast, traditional funds are typically valued and settled only once a day, limiting flexibility when rapid intervention is needed.

Greater portfolio transparency is another element particularly valued by investors (51%). Conversely, barely 11% of respondents identified tax efficiency as a benefit.

Chart 1: Top factors when choosing an active ETF

Source: Schroders Global Investor Insights Study 2026. The survey question was: “When considering an active ETF, which of the following advantages are most important to you?”, and respondents were asked to rank their top three reasons.

How do investors use active ETFs?

The survey points out that investors incorporate active ETFs as flexible components within portfolio construction. They allow them to express their investment convictions, access differentiated exposures, and complement their core positions, while maintaining high operational efficiency.

This is structured mainly on two levels. On one hand, investors consider that active ETFs play a relevant role in diversification (68%). On the other hand, they also point to them as a core component in building their investment portfolios (38%).

Tom Stephens, Head of ETFs at Schroders, noted: “The appeal of active ETFs lies in the simplicity of the vehicle and the ease with which they can be integrated, both strategically and tactically. Strategically, they can serve as core equity or fixed income exposure; tactically, they allow positioning in duration, themes, or sectors. And it’s not just a matter of costs: the ability to trade intraday across different platforms facilitates making rapid adjustments, with greater transparency and operational efficiency than many other instruments. This is especially useful when seeking specific goals, such as diversification or risk management.”

Active ETFs for specialized and harder-to-access markets

The survey also shows that demand for active ETFs is not uniform across all investment areas. Investors especially value active management in areas where markets have less coverage, are less efficient, or present greater structural complexity. This is the case for thematic or sector strategies (49%), small- and mid-cap equities (43%), and emerging market equities (40%).

This highlights that investors are looking for active ETFs to combine ease of trading with active management results that make a real difference, especially when index exposure is less precise or when other vehicles are less operational.

Addressing concerns: returns and con fusion with passive ETFs

Despite the strong momentum of active ETFs, the survey shows that some obstacles to adoption remain, which have more to do with the fund manager than with the structure of the vehicle itself. Thus, nearly half of respondents globally (43%) point to uncertainty regarding the performance of this investment solution compared to active mutual funds, a vehicle that remains dominant and has a long tradition in the market, as the main concern. Meanwhile, the second largest concern expressed by investors (40%) is the unclear differentiation between active and passive ETFs.

These elements suggest that the next phase of growth for active ETFs will largely depend on managers’ ability to demonstrate the robustness of their investment process and explain how strategies are implemented and managed within the ETF fund structure, so that investors can understand them and track them over the long term.

Franklin Templeton Acquires Majority Stake in Stoneshield Capital

  |   By  |  0 Comentarios

Photo courtesyJenny Johnson, CEO of Franklin Templeton.

Franklin Templeton, through its flagship real estate subsidiary Clarion Partners, has announced a definitive agreement to acquire a majority stake in Stoneshield Capital. According to the firm, the transaction will triple Clarion’s assets under management (AUM) in Europe to $13 billion (€11 billion), increase Clarion’s overall AUM by 12% to $82 billion (€72 billion), and boost Franklin Templeton’s total alternative assets under management above $300 billion (€265 billion).

Stoneshield is a leading European manager specializing in sector-specific real assets, with $9 billion (€8 billion) under management. Its thematic investment strategies focus on sectors facing structural supply constraints, including residential and student housing, digital infrastructure, life sciences and innovation, hospitality, and critical infrastructure.

“The addition of Stoneshield represents an important milestone in Clarion’s development of an integrated real assets platform in Europe. Stoneshield’s focus on high-return investments and special situations perfectly complements our existing offering. This transaction expands our global investor relationships, diversifies our product lineup, and reinforces our long-term commitment to delivering strong performance and innovative investment solutions to our clients,” explained David Gilbert, CEO of Clarion Partners.

Expanded Presence in Europe

The manager noted that through the acquisition of Stoneshield, Clarion strengthens its footprint in Europe, complementing its established expertise in institutional logistics assets and net-lease real estate with Stoneshield’s capabilities in digital, residential, and industrial-logistics storage.

Currently, Stoneshield’s investment lineup features a series of diversified closed-end opportunistic funds, as well as an investment platform specifically tailored to the student housing and living sectors. The firm also holds strategic stakes in several of Europe’s leading and fastest-growing real asset platforms.

“We are very excited about the expansion opportunity in Europe, both by scaling Stoneshield’s opportunistic funds business and by developing new strategies around their investment themes. Stoneshield’s strategic stakes in various companies not only have the potential to deliver attractive risk-adjusted returns, but we believe they will also generate new asset-level investment opportunities for current and future investment products,” added Josh Pristaw, President of Clarion Partners.

Stoneshield will serve as Clarion’s specialized platform for opportunistic investments in Europe and will maintain its offices in Spain, Portugal, Ireland, the United Kingdom, and Luxembourg. As part of the transaction, co-founders Juan Pepa and Felipe Morenés remain committed to leading Stoneshield for the long term, retaining responsibility over investment strategy, growth, and the firm’s day-to-day management. Working in close collaboration with Clarion Partners and Franklin Templeton, they will also play a central role in expanding the firm’s European real assets platform, developing new investment strategies across their areas of expertise, and creating innovative products for institutional and private banking clients globally. Together, they will continue to drive strategic growth opportunities through new investment themes, geographical expansion, and selective acquisitions.

Juan Pepa commented: “We are thrilled to join Clarion Partners’ investment management platform and look forward to further scaling the size and scope of our business in supply-constrained growth sectors. The transaction allows us to benefit from the advantages of a global platform while preserving our team, our strategy, and our culture.”

For his part, Felipe Morenés added: “We firmly believe that our partnership with Clarion Partners and Franklin Templeton will accelerate our growth and reinforce our commitment to generating value for our clients, backed by the long-term positive structural fundamentals of real asset investing across Europe.”

Franklin Templeton’s Strategy

According to Jenny Johnson, CEO of Franklin Templeton, Stoneshield has built an extraordinary track record of superior risk-adjusted returns, and its integration into Clarion’s platform will position the team ideally for continued robust growth.

“We are delighted to welcome Stoneshield to Franklin Templeton. This combination strengthens our real asset capabilities in Europe and creates opportunities to extend the strengths of both Stoneshield and Clarion across different geographies. This acquisition represents another important step in our strategy to globalize our real asset capabilities, expand our private markets business, and enhance our offering for clients worldwide,” stated Johnson.

The transaction is expected to close during the fourth calendar quarter of 2026, subject to customary closing conditions, including required regulatory filings.

MetLife Investment Management Hires Roger Goncalves to Accelerate Global Expansion

  |   By  |  0 Comentarios

Photo courtesy

MetLife Investment Management has strengthened its commercial and institutional client relations team with the addition of Roger Goncalves, who assumed the position of Senior Vice President, Global Client Group, according to an announcement made by the executive on LinkedIn.

The move places an executive with an extensive track record in investment product distribution at the helm of a role vital to the growth of one of the asset management platforms undergoing significant transformation recently.

Goncalves brings experience in distribution and platform strategy. Prior to joining MetLife Investment Management, he spent a major portion of his career at Franklin Templeton, where he served as Senior Vice President and Head of Global Financial Institutions for the Americas.

In that role, he was responsible for strategic relationships with global financial institutions, including key accounts, intermediaries, and investment research teams across the firm’s distribution network in the Americas.

His career also includes positions at RBC Global Asset Management, J.P. Morgan Asset Management, Permal Group, and AllianceBernstein, with a strong focus on international distribution and UCITS products for non-resident clients.

A Move Amid MetLife’s Expansion

Goncalves’ arrival comes as MetLife Investment Management accelerates its growth strategy. The manager held $736.3 billion in assets under management as of the end of March 2026, according to its most recent figures. Of that total, $313.2 billion corresponded to institutional client assets.

The platform manages investments for various client types, including insurance companies, pension funds, intermediaries, sovereign wealth funds, and other institutional investors.

By segment, MetLife Investment Management’s institutional assets included $125.2 billion from insurers, $87.8 billion from pension funds, $61.0 billion from intermediaries, and $11.9 billion from sovereign wealth funds.

The scale of operations expanded significantly after MetLife Investment Management completed the acquisition of PineBridge Investments in late 2025. The integration established the platform as an even more prominent player in markets such as public and private fixed income, real estate, equities, alternatives, and multi-asset solutions. MetLife noted in its first-quarter presentation that the platform employed approximately 1,400 professionals across 35 cities.

Furthermore, the company set a ambitious target: driving MetLife Investment Management’s assets under management toward $1 trillion.

Commercial Talent Gains Weight in Asset Management

In this context, Goncalves’ appointment carries significance beyond an individual firm transition.

For major global asset managers, growing assets under management relies not solely on possessing competitive investment capabilities. It also requires building long-term relationships with insurance companies, pension funds, banks, distribution platforms, consultants, and other major capital allocators.

This is precisely where much of Goncalves’ professional background lies. Prior to Franklin Templeton, the executive was Managing Director of Americas Offshore at RBC Global Asset Management, where he was responsible for developing the UCITS distribution business across the Americas. He subsequently served as Vice President–Offshore Client Advisor at J.P. Morgan Asset Management, overseeing the UCITS non-resident client business.

He also held a vice presidency for the Americas at Permal Group, an asset manager specializing in alternative investments, and was previously Vice President–International at AllianceBernstein, where he was responsible for UCITS distribution in the non-resident market.

His profile thus combines institutional distribution, platform expertise, and international market experience—three key areas for an asset manager aiming to expand its presence among global investors.

MetLife Seeks to Scale Its Platform

MetLife Investment Management’s growth strategy is also reflected in the performance of some of its core investment areas.

During 2025, the asset manager originated approximately $26 billion in private fixed-income transactions, bringing the platform’s assets under management in this category to $144.7 billion by year-end. Origination encompassed corporate debt, infrastructure, residential credit, and asset-backed finance.

Added to this is the growth of its alternative investments business. In August 2026, MetLife Investment Management announced the closing of a $1.2 billion private equity fund, reinforcing its footprint in private markets.

The strategy points toward a diversified platform with a significant emphasis on public and private fixed income. As of March 2026, approximately 72% of MetLife Investment Management’s assets were tied to public and private fixed income.

Goncalves’ appointment therefore occurs at a stage when the asset manager needs to convert this scale and investment capacity into deeper market penetration among institutional clients and distribution channels.

The role he assumes within the Global Client Group—led by Sergio Ramírez and responsible for distribution and sales—aligns directly with that strategy.

With Goncalves’ addition, MetLife Investment Management gains expertise in one of the global asset management industry’s most competitive segments: converting a large-scale investment platform into lasting commercial relationships with major capital allocators.

Juliana Herrmann Joins UBS International to Strengthen Its Business with Latin American Clients

  |   By  |  0 Comentarios

Photo courtesy

UBS has bolstered its international banking operations in New York with the addition of Juliana Herrmann, an executive with over two decades of experience in financial services and a track record closely tied to high-net-worth Latin American clients.

The appointment was announced by Fabian Ochsner, Market Director at UBS in New York, who reported that Herrmann is joining UBS International within the New York International Market, under the leadership of Market Executive Michael Sarlanis and the institution’s executive team.

Herrmann’s arrival strengthens UBS’s international platform in one of the world’s primary financial centers and, in particular, its ability to serve clients with international wealth—a segment where the relationship between the United States and Latin America continues to grow in importance.

Herrmann joins from J.P. Morgan, where she served as Executive Director in the International Private Bank, advising ultra-high-net-worth Brazilian clients. Her private banking background is complemented by an extensive history in Latin American investment banking.

Prior to joining J.P. Morgan’s private banking business, she worked for over a decade in its Latin America Investment Banking division, participating in M&A transactions, capital markets, and various strategic initiatives.

During that period, she advised on operations across sectors such as agribusiness, technology, media, energy, and industrials, participating in several significant transactions for Latin American companies.

The combination of both disciplines—investment banking and ultra-high-net-worth management—is particularly relevant to the international wealth management business, where client needs extend beyond traditional portfolio management.

For Latin American ultra-high-net-worth individuals, wealth management is typically linked to international structures, estate planning, geographical diversification, alternative investments, and access to global markets. Consequently, the expertise of professionals who understand both corporate and private wealth needs can prove to be a key asset for major financial institutions.

From Investment Banking to Wealth Management

Herrmann began her professional career in corporate finance at Ernst & Young in São Paulo before joining J.P. Morgan. Over a career spanning more than 20 years, she seamlessly transitioned between investment banking and directly advising ultra-high-net-worth clients.

Her profile also reflects the international scope of the role. She is fluent in Portuguese and English, with working knowledge of Spanish and German—a combination particularly suited for a platform like UBS International, which serves clients with global needs.

Herrmann earned her degree in Political Science and Economics, with honors, from Fundação Armando Álvares Penteado in São Paulo. The move comes at a time when major international banks are competing not only to manage assets, but also to attract and retain professionals capable of building long-term relationships with business families and prominent investors.

In this market, New York retains a strategic position as a platform for Latin American capital seeking international diversification, access to U.S. markets, and sophisticated wealth planning services.

Herrmann’s appointment at UBS joins a broader competition for specialized talent in wealth management and international private banking, particularly among professionals who combine deep knowledge of Latin American markets with expertise in managing ultra-high-net-worth wealth.

More than an individual career move, the transition underscores the ongoing importance of specialized Latin American market expertise within major global wealth management platforms.